Sanofi Withdraws Zimulti NDA For Weight Loss
This article was originally published in The Pink Sheet Daily
Executive Summary
Company cites confusion over concerns raised by the Endocrinologic and Metabolic Drugs Advisory Committee, which voted against approval June 13.